Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
Methode Electronics
MEI
$646M
| $1.51M | ﹤0.01% |
45,016
-36,003
| -44% | -$1.47M |
|
3652
PUT
Idexx Laboratories
IDXX
$43.7B
| $1.51M | ﹤0.01% |
3,000
+200
| +7% | +$95.8K |
|
3653
Verrica Pharmaceuticals
VRCA
$97.7M
| $1.5M | ﹤0.01% |
26,061
+8,240
| +46% | +$500K |
|
3654
Park-Ohio Holdings
PKOH
$663M
| $1.5M | ﹤0.01% |
79,016
-39,782
| -33% | -$605K |
|
3655
CALL
Paychex
PAYX
$45.2B
| $1.5M | ﹤0.01% |
13,400
-8,300
| -38% | -$908K |
|
3656
Huazhu Hotels Group
HTHT
$14.7B
| $1.5M | ﹤0.01% |
38,652
+15,928
| +70% | +$692K |
|
3657
Core & Main
CNM
$8.05B
| $1.5M | ﹤0.01% |
47,809
-423,654
| -90% | -$11.3M |
|
|
UHT
3658
Universal Health Realty Income Trust
UHT
$576M
| $1.5M | ﹤0.01% |
+31,425
| New | +$1.44M |
|
3659
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
$7.01B
| $1.49M | ﹤0.01% |
+109,700
| New | +$1.53M |
|
3660
CALL
Vale
VALE
$64B
| $1.49M | ﹤0.01% |
111,100
-42,100
| -27% | -$596K |
|
|
WKME
3661
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $1.49M | ﹤0.01% |
+155,203
| New | +$1.5M |
|
3662
ORIX
IX
$42.4B
| $1.49M | ﹤0.01% |
+81,535
| New | +$1.41M |
|
3663
ACI Worldwide
ACIW
$5.43B
| $1.49M | ﹤0.01% |
+64,163
| New | +$1.55M |
|
3664
Mercury Systems
MRCY
$5.32B
| $1.48M | ﹤0.01% |
42,904
-73,284
| -63% | -$3.13M |
|
3665
IDT Corp
IDT
$1.72B
| $1.48M | ﹤0.01% |
57,325
-13,988
| -20% | -$432K |
|
3666
Repligen
RGEN
$9.95B
| $1.48M | ﹤0.01% |
10,457
-17,226
| -62% | -$2.76M |
|
3667
CALL
Capital One
COF
$132B
| $1.48M | ﹤0.01% |
13,500
-106,300
| -89% | -$10.6M |
|
3668
Bridgewater Bancshares
BWB
$594M
| $1.48M | ﹤0.01% |
149,822
+126,891
| +553% | +$1.22M |
|
3669
CALL
Centene
CNC
$32B
| $1.47M | ﹤0.01% |
21,800
-14,800
| -40% | -$987K |
|
3670
CALL
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$299M
| $1.47M | ﹤0.01% |
+50,000
| New | +$1.46M |
|
3671
J. Jill
JILL
$296M
| $1.46M | ﹤0.01% |
68,210
-35,447
| -34% | -$814K |
|
3672
CALL
Natera
NTRA
$47B
| $1.46M | ﹤0.01% |
+30,000
| New | +$1.53M |
|
3673
PUT
Nokia
NOK
$57.2B
| $1.46M | ﹤0.01% |
+350,700
| New | +$1.48M |
|
3674
Harvard Bioscience
HBIO
$36.1M
| $1.46M | ﹤0.01% |
26,565
+13,227
| +99% | +$726K |
|
3675
Identive
INVE
$66.9M
| $1.46M | ﹤0.01% |
173,398
+154,351
| +810% | +$1.05M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.